Phase 1/2a Study of SQ3370 in Patients With Advanced Solid Tumors
NCT04106492
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
TERMINATED
Status
53
Enrollment
INDUSTRY
Sponsor class
Stopped
Sponsor's decision
Conditions
Cancer
Interventions
DRUG:
SQ3370
Sponsor
Shasqi, Inc.